GO
Loading...

Sanofi SA

More

  • China Rolls Up Sleeves in Fight Against Bird Flu Friday, 5 Apr 2013 | 12:32 AM ET

    China said it was mobilizing resources nationwide to combat a new strain of bird flu that has killed six people, as Japan, Hong Kong and the United States stepped up vigilance.

  • Pro's Best Buys in Health Care Tuesday, 26 Mar 2013 | 1:21 PM ET

    A few health care stocks still hold potential, Orbimed Advisors Managing Partner Sam Isaly says.

  • Weak Euro can be Good for Exporters  Monday, 25 Mar 2013 | 11:05 PM ET

    Simon Grose-Hodge, Head of Investment Advisory, Singapore at LGT Bank talks Cyprus and tells CNBC's Cash which stocks will benefit from the weak euro.

  • 4 Biotech Stock Stars Losing Their Luster Thursday, 21 Feb 2013 | 12:19 PM ET

    These four biotech stocks could take a big hit when investors start to focus on lower-valued stocks in other industries. TheStreet.com reports.

  • Stocks finished slightly lower in lackluster trading Monday as investors remained cautious amid a lack of new market catalysts following the recent rally that helped the S&P 500 end its sixth-consecutive week higher.

  • Midday Movers: REGN, FOSL & More Monday, 11 Feb 2013 | 2:17 PM ET

    Take a look at some of Monday midday movers:

  • Europe Stocks Mixed, Healthcare Weighs Monday, 11 Feb 2013 | 10:52 AM ET

    European shares closed lower on Monday as sharp falls in Danish pharma group Novo Nordisk outweighed rallies in rival Sanofi and Dutch retailer Ahold.

  • Early Movers: DELL, GOOG, SNY & More Monday, 11 Feb 2013 | 8:22 AM ET

    Some of the names on the move ahead of the open.

  • U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.

  • Sanofi Leads European Shares to 2013 Closing Low Thursday, 7 Feb 2013 | 9:31 AM ET

    European shares closed lower after choppy trading on Thursday, tracking falls on the U.S. equity markets.

  • Different Approach to Innovation: Sanofi CEO  Thursday, 7 Feb 2013 | 4:20 AM ET

    Christopher Viehbacher, CEO of Sanofi, pledges a different and radical approach to innovation.

  • Pfizer's animal health subsidiary Zoetis raised $2.2 billion in its public offering on Thursday, becoming the largest IPO from a U.S. company since Facebook.

  • Denmark's Nokia Moment on $100 Billion Stock Friday, 1 Feb 2013 | 6:37 AM ET
    Copenhagen, Denmark

    Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech boom.

  • Denmark Faces Nokia Moment on $100 Billion Stock Friday, 1 Feb 2013 | 5:28 AM ET

    Denmark is facing its "Nokia moment"; drugmaker Novo Nordisk has ballooned into a $100 billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech boom.

  • Drug Pipelines Begin to Fill For Big Pharma Sunday, 13 Jan 2013 | 4:30 PM ET

    The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.

  • Pipeline Winners: Should You Bank on Biotech? Friday, 11 Jan 2013 | 5:09 PM ET

    Jim Cramer’s researcher Nicole Urken reviews the potential biotech pipeline winners there were highlighted this week on Mad Money.

  • Flu Reaches Epidemic Level in U.S.  Friday, 11 Jan 2013 | 4:40 PM ET

    Widespread influenza activity has afflicted 47 states, according to the CDC. Phil Hosbach, VP of Immunization Policy, discusses whether people should be worried about dwindling supplies.

  • Sanofi CEO on Fighting the Flu  Monday, 7 Jan 2013 | 4:40 PM ET

    Chris Viehbacher, CEO of Sanofi, discusses growing concern over the spread of the flu this season.

  • Europe Closes Slightly Higher in Shortened Session Monday, 31 Dec 2012 | 5:24 AM ET

    European stocks were flat in early afternoon trading on Monday as fears over a lack of resolution to the U.S.' "fiscal cliff" weighed on sentiment.

  • Big Pharma Bets on Obesity Drug Binge Thursday, 27 Dec 2012 | 2:18 AM ET

    As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.